| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly demonstrates a strong commitment to product development and innovation, with significant advancements in weight-loss and obesity drug development. Their collaboration with Ascidian Therapeutics in genetic medicines further diversifies their portfolio and bolsters their capacity for addressing rare diseases. Successful next-generation drug launches and an expanding product pipeline indicate a proactive approach to growth and risk management. Overall, the company is well-positioned to capitalize on emerging trends in healthcare. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 3 is extremely bullish. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.5, and the negative at -1 on 2026-06-08. The forces of Sentiment towards Fundamentals (3.2), Stock Price Trend (3), Valuation Sentiment (1.4), Option Sentiment (0.8), and Sector Price Trend (0.6) will drive up the price. The forces of Price Level Sentiment (-0.5), and Market Risk Appetite (-5.4) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-08 | 1%(0.1%) | 1148.97 | 4.59% | 94 | 1.41% | 0.76% | 3 | -0.2 | 1.2% | 0.5 | Wait | 50% | 3.2 | 5.1 |
| 2026-06-07 | 0%(0%) | 2.2 | -0.2 | -0.1 | 2.7 | -1 | ||||||||
| 2026-06-06 | 0%(0%) | 2.2 | -0.2 | -0.1 | 3.1 | -1 | ||||||||
| 2026-06-05 | 0%(0%) | 1133.01 | 4.71% | 90 | 0.69% | 0.85% | 2.2 | -0.3 | 2.1% | -0.1 | Wait | 50% | 3.4 | -1 |
| 2026-06-04 | 0%(0%) | 1125.3 | 4.6% | 92 | 3.92% | 1% | 1.7 | 0.3 | 2.3% | 0.3 | Long | 55% | 3.5 | 5 |
| 2026-06-03 | 0%(0%) | 1082.87 | 4.52% | 76 | 1.69% | 0.57% | 1.1 | 0.1 | 0.8% | 0.5 | Long | 55% | 4.2 | 2.7 |
| 2026-06-02 | 0%(0%) | 1064.84 | 4.54% | 69 | -1.58% | 0.73% | 1.2 | -0.4 | 1.1% | 0.6 | Wait | 50% | 4.8 | -1 |
| 2026-06-01 | 0%(0.1%) | 1081.96 | 4.55% | 80 | -2.17% | 0.73% | 1.6 | -0.2 | 1.7% | 1 | Long | 65% | 4.9 | -1 |
| 2026-05-31 | 0%(0.1%) | 3 | -0.2 | 1.3 | 5 | -1 | ||||||||
| 2026-05-30 | 0%(0.1%) | 3 | -0.2 | 1.3 | 5 | 7 | ||||||||
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Analysis | ||
| ● Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026 | ||
| 2026-06-08 22:49:02 The successful late-stage trial of Eli Lilly's next-generation weight-loss drug highlights advancements in product development and potential market impact. |
| 2026-06-08 22:49:02 The rise in Eli Lilly's stock price following positive announcements about a new weight-loss drug trial is a significant indicator of strong market performance. |
| 2026-06-08 17:48:14 The competitive landscape between Eli Lilly and Novo Nordisk intensifies as both companies launch similar products. |
| 2026-06-08 17:48:14 Despite positive news on weight-loss drugs, the stocks of Eli Lilly and Novo Nordisk reacted differently in the market. |
| 2026-06-08 17:48:14 Both Eli Lilly and Novo Nordisk are developing effective weight-loss drugs, reflecting innovation in healthcare. |
| 2026-06-08 17:01:50 The success of Eli Lilly's next-generation drugs signifies strong product development capabilities within the company. |
| 2026-06-08 17:01:50 Positive responses from analysts regarding Eli Lilly's drug trials have bolstered investor confidence. |
| 2026-06-08 17:01:50 Eli Lilly is navigating competitive dynamics in the weight-loss drug market against rivals like Novo Nordisk. |
| 2026-06-08 17:01:50 The share price of Eli Lilly has shown significant fluctuations based on new drug data and market reactions. |
| 2026-06-08 17:01:50 Eli Lilly's positive data and product development are positioning it as a leader in the rapidly expanding weight-loss market. |
| 2026-06-08 15:48:50 The varying stock market reactions to good news regarding weight-loss drugs illustrate how medical advancements can influence investor sentiments and stock performance. |
| 2026-06-08 15:48:50 The competition between Eli Lilly and Novo Nordisk in the weight-loss drugs market is highlighted, showcasing differing stock market reactions despite positive news. |
| 2026-06-08 13:48:34 The contrasting stock movements of Eli Lilly and Novo Nordisk following their announcements reflect mixed investor sentiment around the future of weight-loss pharmaceuticals. |
| 2026-06-08 13:48:34 The market's response to recent drug trial results has led to notable stock fluctuations, highlighting the relationship between clinical outcomes and investor confidence. |
| 2026-06-08 13:48:34 The competition in the weight-loss drug market is heating up with companies like Eli Lilly and Novo Nordisk presenting promising outcomes for their drug developments, influencing stock performances. |
| 2026-06-08 09:36:22 The emerging competition between Eli Lilly and Novo Nordisk showcases the competitive landscape in the weight-loss drug sector. |
| 2026-06-08 09:36:22 Positive analyst evaluations regarding the late-stage trial results for Eli Lilly's weight-loss drug reflect optimistic forecasts about its market potential. |
| 2026-06-08 09:36:22 The contrasting reactions of Eli Lilly and Novo Nordisk stocks indicate varying investor confidence and market sentiments regarding their weight-loss drug announcements. |
| 2026-06-08 09:36:22 The positive advancements in the development of weight-loss drugs by Eli Lilly and Novo Nordisk highlight significant progress in the pharmaceutical industry. |